ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences

Rhea-AI Summary

ImmunoGen, Inc. (NASDAQ: IMGN), a leader in antibody-drug conjugates (ADCs) for cancer treatment, announced upcoming presentations at investor conferences. The first is at the William Blair 42nd Annual Growth Stock Conference on June 8 at 11:20am CT/ 12:20pm ET. The second will be at the Jefferies Healthcare Conference on June 9 at 9:30am ET. Webcasts will be available on the company’s website, along with replays after the events. ImmunoGen aims to improve cancer treatment outcomes through innovative ADCs.

WALTHAM, Mass.--(BUSINESS WIRE)-- ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

• William Blair 42^nd Annual Growth Stock Conference
  June 8 at 11:20am CT / 12:20pm ET

• Jefferies Healthcare Conference
  June 9 at 9:30am ET

A webcast of each presentation will be accessible through the “Investors and Media” section of the Company’s website, www.immunogen.com. Following the live webcast, a replay will be available at the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™.

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005263/en/

INVESTOR RELATIONS AND MEDIA

ImmunoGen

Courtney O'Konek

781-895-0600

courtney.okonek@immunogen.com

OR

FTI Consulting

Robert Stanislaro

212-850-5657

robert.stanislaro@fticonsulting.com

Source: ImmunoGen, Inc.

FAQ

When will ImmunoGen present at the William Blair 42nd Annual Growth Stock Conference?

ImmunoGen will present at the William Blair 42nd Annual Growth Stock Conference on June 8 at 11:20am CT / 12:20pm ET.

What is the date and time of ImmunoGen's presentation at the Jefferies Healthcare Conference?

ImmunoGen's presentation at the Jefferies Healthcare Conference is scheduled for June 9 at 9:30am ET.

Where can I access the webcasts of ImmunoGen's upcoming presentations?

The webcasts of ImmunoGen's upcoming presentations can be accessed through the 'Investors and Media' section of their website.

What is the focus of ImmunoGen's research and development?

ImmunoGen focuses on developing next-generation antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.

What commitment does ImmunoGen make towards cancer treatment?

ImmunoGen is committed to TARGET A BETTER NOW™, aiming to disrupt cancer progression with targeted therapies.